Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.

Autor: Dreyton CJ; Department of Chemistry and The Kellogg School of Graduate Studies, The Scripps Research Institute-Florida, 130 Scripps Way, Jupiter, FL 33458, United States., Anderson ED; Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States., Subramanian V; Department of Chemistry and The Kellogg School of Graduate Studies, The Scripps Research Institute-Florida, 130 Scripps Way, Jupiter, FL 33458, United States., Boger DL; Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States., Thompson PR; Department of Chemistry and The Kellogg School of Graduate Studies, The Scripps Research Institute-Florida, 130 Scripps Way, Jupiter, FL 33458, United States. Electronic address: pthompso@scripps.edu.
Jazyk: angličtina
Zdroj: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2014 Feb 15; Vol. 22 (4), pp. 1362-9. Date of Electronic Publication: 2014 Jan 08.
DOI: 10.1016/j.bmc.2013.12.064
Abstrakt: Protein citrullination is just one of more than 200 known PTMs. This modification, catalyzed by the protein arginine deiminases (PADs 1-4 and PAD6 in humans), converts the positively charged guanidinium group of an arginine residue into a neutral ureido-group. Given the strong links between dysregulated PAD activity and human disease, we initiated a program to develop PAD inhibitors as potential therapeutics for these and other diseases in which the PADs are thought to play a role. Streptonigrin which possesses both anti-tumor and anti-bacterial activity was later identified as a highly potent PAD4 inhibitor. In an effort to understand why streptonigrin is such a potent and selective PAD4 inhibitor, we explored its structure-activity relationships by examining the inhibitory effects of several analogues that mimic the A, B, C, and/or D rings of streptonigrin. We report the identification of the 7-amino-quinoline-5,8-dione core of streptonigrin as a highly potent pharmacophore that acts as a pan-PAD inhibitor.
(Copyright © 2014 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: